AN EXPERIMENTAL MODEL FOR CHORIOAMNIONITIS AND PREMATURITY
AN EXPERIMENTAL MODEL FOR CHORIOAMNIONITIS AND PREMATURITY
批准号:
7348889
负责人:
MICHAEL G GRAVETT
金额:
$7.68万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-05-01 至 2007-04-30
中文摘要
该子项目是利用NIH/NCRR资助的中心赠款提供的资源的许多研究子项目之一。子项目和研究者(PI)可能从另一个NIH来源获得主要资金,因此可以在其他CRISP条目中表示。所列机构为中心,不一定是研究者所在机构。早产及其后果仍然是产科最重要的问题。12%的早产新生儿占非先天性畸形新生儿死亡的80%。宫内感染是早产的一个重要原因,也是可以预防的。本研究的长期目标是:a)阐明感染性早产的病理生理机制; B)建立宫内感染和早产之间的细胞和分子联系; c)测试感染背景下早产的合理干预策略的有效性。我们相信,如果成功,这些研究将促进适当的人类干预试验的快速发展。我们已经开发了第一个实验模型,在非人类灵长类动物使用长期插管妊娠恒河猴(胎盘和分娩的激素控制类似于人类),其中宫内感染是建立羊膜内接种已知浓度的特定微生物(B组链球菌)。在实验性羊膜内感染后,会相继产生促炎细胞因子、胰高血糖素和基质金属蛋白酶(MMPs)。然后,在所有情况下,子宫收缩,分娩和分娩,通常在72小时内。最近,我们证明,感染引起的早产可以抑制,并延长妊娠,全身和/或羊膜腔内治疗与非特异性免疫调节剂(白细胞介素-10或地塞米松)或前列腺素合成酶抑制剂(吲哚美辛)和适当的抗生素。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Prematurity, and its consequences, remain the most important problem in obstetrics. The 12% of neonates born prematurely account for 80% of neonatal deaths not attributable to congenital malformations. Intrauterine infections are an important, and potentially preventable, cause of preterm delivery. The long-term objectives of this research are: a) to elucidate the pathophysiologic mechanisms of infection-induced preterm labor; b) to establish the cellular and molecular links among intrauterine infection and preterm labor; and c) to test the efficacy of rational interventional strategies for preterm labor in the setting of infection. It is our belief that if successful, these studies will facilitate the rapid development of appropriate human interventional trials. We have developed the first experimental model in a nonhuman primate using chronically catheterized pregnant rhesus monkeys (both placentation and the hormonal control of parturition are similar to humans) in which intrauterine infection is established by the intraamniotic inoculation of known concentrations of a specific microorganism (Group B Streptococcus). Following experimental intraamniotic infection, there is sequential production of the proinflammatory cytokines, prostaglandins, and matrix metalloproteinases (MMPs). This is then followed in all cases by uterine contraction, labor and delivery, usually within 72 hours. Recently, we demonstrated that infection-induced preterm labor can be inhibited, and gestation prolonged, by systemic and/or intraamniotic treatment with non-specific immunomodulators (interleukin-10 or dexamethasone) or prostaglandin syntase inhibitors (indomethacin) and appropriate antibiotics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
AN EXPERIMENTAL MODEL FOR CHORIOAMNIONITIS AND PREMATURITY
-
批准号:7561875
-
项目类别:
-
资助金额:$7.59万
-
财政年份:2007
-
负责人:MICHAEL G GRAVETT
-
依托单位:
AN EXPERIMENTAL MODEL FOR CHORIOAMNIONITIS AND PREMATURITY
-
批准号:7165203
-
项目类别:
-
资助金额:$7.47万
-
财政年份:2005
-
负责人:MICHAEL G GRAVETT
-
依托单位:
AN EXPERIMENTAL MODEL FOR CHORIOAMNIONITIS AND PREMATURITY
-
批准号:6970640
-
项目类别:
-
资助金额:$8.22万
-
财政年份:2004
-
负责人:MICHAEL G GRAVETT
-
依托单位:
INTERLEUKIN 10 INHIBITS INTERLEUKIN 1? INDUCED PRETERM LABOR IN RHESUS MONKEYS
-
批准号:6592311
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2002
-
负责人:MICHAEL G GRAVETT
-
依托单位:
INTERLEUKIN 10 INHIBITS INTERLEUKIN 1? INDUCED PRETERM LABOR IN RHESUS MONKEYS
-
批准号:6453687
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2001
-
负责人:MICHAEL G GRAVETT
-
依托单位:
INTERLEUKIN 10 INHIBITS INTERLEUKIN 1? INDUCED PRETERM LABOR IN RHESUS MONKEYS
-
批准号:6116159
-
项目类别:
-
资助金额:$9.03万
-
财政年份:1999
-
负责人:MICHAEL G GRAVETT
-
依托单位:
EXPERIMENTAL MODEL FOR CHORIODECIDUAL INFECTION & PRETERM LABOR IN MACAQUES
-
批准号:6277391
-
项目类别:
-
资助金额:$7.42万
-
财政年份:1998
-
负责人:MICHAEL G GRAVETT
-
依托单位:
INTERLEUKIN 10 INHIBITS PRETERM UTERINE CONTRACTIONS INDUCED BY INTERLEUKIN 1
-
批准号:6277398
-
项目类别:
-
资助金额:$7.42万
-
财政年份:1998
-
负责人:MICHAEL G GRAVETT
-
依托单位:
INDUCTION OF HEAT SHOCK PROTEIN BY INTERLEUKIN 1 INTRAAMNIOTIC INFUSION
-
批准号:6277397
-
项目类别:
-
资助金额:$7.42万
-
财政年份:1998
-
负责人:MICHAEL G GRAVETT
-
依托单位:
Experimental Model for Chorioamnionitis and Prematurity
-
批准号:6631996
-
项目类别:
-
资助金额:$27.83万
-
财政年份:1997
-
负责人:MICHAEL G GRAVETT
-
依托单位:
Experimental Model for Chorioamnionitis and Prematurity
-
批准号:6763049
-
项目类别:
-
资助金额:$27.83万
-
财政年份:1997
-
负责人:MICHAEL G GRAVETT
-
依托单位:
EXPERIMENTAL MODEL FOR CHORIOAMNIONITIS AND PREMATURITY
-
批准号:2673171
-
项目类别:
-
资助金额:$19.85万
-
财政年份:1997
-
负责人:MICHAEL G GRAVETT
-
依托单位:
EXPERIMENTAL MODEL FOR CHORIOAMNIONITIS AND PREMATURITY
-
批准号:2542415
-
项目类别:
-
资助金额:$19.53万
-
财政年份:1997
-
负责人:MICHAEL G GRAVETT
-
依托单位:
Experimental Model for Chorioamnionitis and Prematurity
-
批准号:6510793
-
项目类别:
-
资助金额:$27.83万
-
财政年份:1997
-
负责人:MICHAEL G GRAVETT
-
依托单位:
Experimental Model for Chorioamnionitis and Prematurity
-
批准号:6894782
-
项目类别:
-
资助金额:$27.83万
-
财政年份:1997
-
负责人:MICHAEL G GRAVETT
-
依托单位:
EXPERIMENTAL MODEL FOR CHORIOAMNIONITIS AND PREMATURITY
-
批准号:2887671
-
项目类别:
-
资助金额:$20.45万
-
财政年份:1997
-
负责人:MICHAEL G GRAVETT
-
依托单位:
Experimental Model for Chorioamnionitis and Prematurity
-
批准号:6400303
-
项目类别:
-
资助金额:$27.83万
-
财政年份:1997
-
负责人:MICHAEL G GRAVETT
-
依托单位:
DVMT OF NON HUMAN PRIMATE MODEL RELATION OF MATERNAL GENITAL TRACT INFECTIONS
-
批准号:3868654
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MICHAEL G GRAVETT
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于术中实时影像的SAM(Segment anything model)开发AI指导房间隔穿刺位置决策的增强现实模型
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:居维竹
-
依托单位:
Development of a Linear Stochastic Model for Wind Field Reconstruction from Limited Measurement Data
-
批准号:--
-
项目类别:--
-
资助金额:40万元
-
批准年份:2020
-
负责人:Vikrant Gupta
-
依托单位:
应用Agent-Based-Model研究围术期单剂量地塞米松对手术切口愈合的影响及机制
-
批准号:81771933
-
项目类别:面上项目
-
资助金额:50.0万元
-
批准年份:2017
-
负责人:周全红
-
依托单位:
基于Multilevel Model的雷公藤多苷致育龄女性闭经预测模型研究
-
批准号:81503449
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2015
-
负责人:张弛
-
依托单位:
基于非齐性 Makov model 建立病证结合的绝经后骨质疏松症早期风险评估模型
-
批准号:30873339
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2008
-
负责人:谢雁鸣
-
依托单位: